title: [Not Available].
abstract: The purpose of this paper is to examine the eventual benefits of treatment with calcium channel blockers in post-myocardial infarction, through an overview of main placebo-controlled trials that have been conducted to test this therapeutic in acute coronary syndromes. It appears obvious that the vast majority of these trials was conducted in the pre-reperfusion era and failed to demonstrate a reduction in mortality. To conclude, the superiority of a therapy with calcium antagonists over a placebo in the management of post-myocardial infarction remains unknown. In contrast, adverse effects associated with the prescription of calcium antagonists are well known.
authors.forename: Pierre-Vladimir
authors.initials: PV
authors.lastname: Ennezat
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Auffray
authors.forename: Julie
authors.initials: J
authors.lastname: Darchis
authors.forename: Maxime
authors.initials: M
authors.lastname: Ronsselle
authors.forename: Xavier
authors.initials: X
authors.lastname: Gonin
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Aubert
authors.forename: Jean-Jacques
authors.initials: JJ
authors.lastname: Bauchart
authors.forename: Christophe
authors.initials: C
authors.lastname: Bauters
authors.forename: Eric
authors.initials: E
authors.lastname: Van Belle
authors.forename: Philippe
authors.initials: P
authors.lastname: Asseman
keywords: calcium channel blockers; essais cliniques; infarctus du myocarde; inhibiteurs calciques; myocardial infarction; randomized trials